Eli Lilly & Co: (NYSE: LLY)
$54.92
-0.22 (-0.40%)
Volume 4,463,729
May 22 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Cash flow Statements
Annual Cash Flow Statement
Fiscal Year End for LILLY ELI & CO falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 12/31/12 | 12/31/11 | 12/31/10 | 12/31/09 | 12/31/08 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | 4,088.60 | 4,347.70 | 5,069.50 | 4,328.80 | -2,071.90 |
| Depreciation/Amortization & Depletion | 1,462.20 | 1,373.60 | 1,328.20 | 1,297.80 | 1,122.60 |
| Net Change from Assets/Liabilities | -51.20 | 1,248.40 | -185.50 | -956.90 | 2,347.80 |
| Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | -194.80 | 264.80 | 644.60 | -334.20 | 5,897.10 |
| Net Cash From Operating Activities | 5,304.80 | 7,234.50 | 6,856.80 | 4,335.50 | 7,295.60 |
| Property & Equipment | -883.40 | -646.70 | -669.70 | -747.30 | -921.50 |
| Acquisition/ Disposition of Subsidiaries | -199.30 | -307.80 | -609.40 | 0.00 | -6,083.00 |
| Investments | -2,722.80 | -2,736.80 | -1,169.00 | 1,074.60 | 142.50 |
| Other Investing Activities | 972.70 | -1,133.10 | -711.70 | -184.50 | -406.80 |
| Net Cash from Investing Activities | -2,832.80 | -4,824.40 | -3,159.80 | 142.80 | -7,268.80 |
Uses of Funds
| 12/31/12 | 12/31/11 | 12/31/10 | 12/31/09 | 12/31/08 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | 4,088.60 | 4,347.70 | 5,069.50 | 4,328.80 | -2,071.90 |
| Depreciation/Amortization & Depletion | 1,462.20 | 1,373.60 | 1,328.20 | 1,297.80 | 1,122.60 |
| Net Change from Assets/Liabilities | -51.20 | 1,248.40 | -185.50 | -956.90 | 2,347.80 |
| Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | -194.80 | 264.80 | 644.60 | -334.20 | 5,897.10 |
| Net Cash From Operating Activities | 5,304.80 | 7,234.50 | 6,856.80 | 4,335.50 | 7,295.60 |
| Property & Equipment | -883.40 | -646.70 | -669.70 | -747.30 | -921.50 |
| Acquisition/ Disposition of Subsidiaries | -199.30 | -307.80 | -609.40 | 0.00 | -6,083.00 |
| Investments | -2,722.80 | -2,736.80 | -1,169.00 | 1,074.60 | 142.50 |
| Other Investing Activities | 972.70 | -1,133.10 | -711.70 | -184.50 | -406.80 |
| Net Cash from Investing Activities | -2,832.80 | -4,824.40 | -3,159.80 | 142.80 | -7,268.80 |
| Issuance (Repurchase) of Capital Stock | -721.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance (Repayment) of Debt | -1,500.60 | -54.60 | 0.10 | 2,400.00 | -649.70 |
| Increase (Decrease) Short-Term Debt | -10.50 | -141.20 | 123.90 | -5,824.20 | 5,060.50 |
| Payment of Dividends & Other Distributions | -2,187.40 | -2,180.10 | -2,165.30 | -2,152.10 | -2,056.70 |
| Other Financing Activities | 0.00 | 6.00 | 19.40 | 42.60 | -8.10 |
| Net Cash from Financing Activities | -4,419.60 | -2,369.90 | -2,021.90 | -5,533.70 | 2,346.00 |
| Effect of Exchange Rate Changes | 43.90 | -110.90 | -144.80 | 21.60 | -96.60 |
| Net Change In Cash & Equivalents | -1,903.70 | -70.70 | 1,530.30 | -1,033.80 | 2,276.20 |
| Cash at Beginning of Period | 5,922.50 | 5,993.20 | 4,462.90 | 5,496.70 | 3,220.50 |
| Cash at End of Period | 4,018.80 | 5,922.50 | 5,993.20 | 4,462.90 | 5,496.70 |
| Diluted Net EPS | 3.66 | 3.90 | 4.58 | 3.94 | -1.89 |
